# Diltiazem in the Treatment of Atrial Fibrillation or Atrial Flutter With Rapid Ventricular Rate

> **NCT05661942** · PHASE4 · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 92 (actual)

## Conditions studied

- Atrial Fibrillation With Rapid Ventricular Response
- Hypotension Drug-Induced

## Interventions

- **DRUG:** Calcium pre-treatment
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05661942
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-30
- **Primary completion:** 2024-11-20
- **Final completion:** 2024-11-20
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2025-11-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05661942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05661942, "Diltiazem in the Treatment of Atrial Fibrillation or Atrial Flutter With Rapid Ventricular Rate". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05661942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*